Dianthus reveals preclinical data for its Phase II neuromuscular candidate

Clinical-stage biotech firm Dianthus Therapeutics has shared preclinical data of its investigational agent DNTH103 being tested in in vitro models of generalised myasthenia gravis (gMG) and chronic d… [+3188 chars]

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute